462 related articles for article (PubMed ID: 28214380)
1. Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.
Pade D; Jamei M; Rostami-Hodjegan A; Turner DB
Biopharm Drug Dispos; 2017 Mar; 38(2):94-114. PubMed ID: 28214380
[TBL] [Abstract][Full Text] [Related]
2. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.
Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A
Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412
[TBL] [Abstract][Full Text] [Related]
3. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
4. Regional Intestinal Permeability in Rats: A Comparison of Methods.
Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
[TBL] [Abstract][Full Text] [Related]
5. Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms.
Dahlgren D; Roos C; Johansson P; Lundqvist A; Tannergren C; Abrahamsson B; Sjögren E; Lennernäs H
Mol Pharm; 2016 Sep; 13(9):3022-33. PubMed ID: 27500599
[TBL] [Abstract][Full Text] [Related]
6. Predicting human intestinal permeability using single-pass intestinal perfusion in rat.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Azarmi Y; Islambolchilar Z; Barzegar S; Barzegar-Jalali M
J Pharm Pharm Sci; 2007; 10(3):368-79. PubMed ID: 17727800
[TBL] [Abstract][Full Text] [Related]
7. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
[TBL] [Abstract][Full Text] [Related]
8. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
9. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
10. Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data.
Sjögren E; Dahlgren D; Roos C; Lennernäs H
Mol Pharm; 2015 Jun; 12(6):2026-39. PubMed ID: 25919764
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two approaches of intestinal absorption by puerarin.
Li H; Dong L; Liu Y; Wang G; Zhang L; Qiao Y
J Pharmacol Toxicol Methods; 2014; 70(1):6-11. PubMed ID: 24674709
[TBL] [Abstract][Full Text] [Related]
12. Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats.
Yao J; Lu Y; Zhou JP
J Pharm Pharm Sci; 2008; 11(3):22-9. PubMed ID: 18801304
[TBL] [Abstract][Full Text] [Related]
13. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
[TBL] [Abstract][Full Text] [Related]
14. Direct In Vivo Human Intestinal Permeability (Peff ) Determined with Different Clinical Perfusion and Intubation Methods.
Dahlgren D; Roos C; Sjögren E; Lennernäs H
J Pharm Sci; 2015 Sep; 104(9):2702-26. PubMed ID: 25410736
[TBL] [Abstract][Full Text] [Related]
15. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
[TBL] [Abstract][Full Text] [Related]
16. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
17. Regional Intestinal Permeability of Three Model Drugs in Human.
Dahlgren D; Roos C; Lundqvist A; Abrahamsson B; Tannergren C; Hellström PM; Sjögren E; Lennernäs H
Mol Pharm; 2016 Sep; 13(9):3013-21. PubMed ID: 27504798
[TBL] [Abstract][Full Text] [Related]
18. Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion.
Lozoya-Agullo I; Zur M; Beig A; Fine N; Cohen Y; González-Álvarez M; Merino-Sanjuán M; González-Álvarez I; Bermejo M; Dahan A
Int J Pharm; 2016 Dec; 515(1-2):201-208. PubMed ID: 27667756
[TBL] [Abstract][Full Text] [Related]
19. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.
Da Silva LC; Da Silva TL; Antunes AH; Rezende KR
J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454
[TBL] [Abstract][Full Text] [Related]
20. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
Falavigna M; Klitgaard M; Steene E; Flaten GE
Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
